Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors

    SBC: ARISAPH PHARMACEUTICALS, INC.            Topic: 102

    DESCRIPTION provided by applicant Cancer is the second leading cause of death after heart disease in the US Chemotherapy is a mainstay of treatment after surgical removal of tumors but the balance of clinical benefit versus disabling or life threatening side effects is often uncertain Genotyping of cancers to identify mutated oncogenes has enabled an era of targeted therapy Drugs targeting ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. A Novel Technology to Produce Yb:Sr-FAP Transparent Laser Host Ceramics in Non-Isotropic Materials

    SBC: Texas Biochemicals Incorporated            Topic: AF14AT26

    ABSTRACT: To fabricate transparent ceramics composed of anisotropic laser gain media, the crystal orientations of micro-domains should be aligned identically. Current method involve application of high magnetic field. Texas Biochemicals Inc. recently developed a novel technology to produce faceted hexagonal prism c axis oriented Yb: Sr-FAP [Yb: Sr5(PO4)3F nanocrystallites and sintered into transp ...

    STTR Phase I 2014 Department of DefenseAir Force
  3. Advancing a novel portable detection method for cannabis intoxication

    SBC: Brain Solutions, LLC            Topic: NIDA

    TBD

    STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  4. Anti- Reflective Surface Structures forInfrared Nonlinear Materials

    SBC: NANOHMICS INC            Topic: AF18AT016

    High-power, high-efficiency, broadly-tunable coherent sources in the mid-wave infrared (MWIR, =35 m) spectral band are coveted for applications relating to infrared (IR) countermeasures, remote chemical sensing, and free-space optical communication. MWIR sources based on optical nonlinear frequency conversion can generate broadly-tunable kilowatt-level coherent radiation over the entire MWIR spect ...

    STTR Phase I 2018 Department of DefenseAir Force
  5. Astrocyte activation by small-molecule ADORA3 agonists: a novel therapy for Alzheimer's disease

    SBC: ASTROCYTE PHARMACEUTICALS INC.            Topic: NIA

    PROJECT SUMMARY Alzheimerandapos s diseaseADis an area of significant unmet need that creates a national burden of$billion annuallyAD is the leading cause of dementiaaffectingof Americans over the age ofDemographic shifts and the age related nature of AD will soon place this disease as the costliest health care expenditure in the U Swith a projected impact of $trillion per year byCurrent therapies ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  6. Biomimetic Design of Morphing Micro Air Vehicles

    SBC: Texas Research Institute, Austin, Inc.            Topic: AF15AT01

    Over the past two decades significant progress has been made on the development of mission capable micro air vehicles (MAV) and small unmanned aircraft systems (sUAS) but the full potential of implementing multifunctional morphing wings using active materials has not been realized.A need exists to develop a MAV wing that can autonomously adapt to flight conditions allowing the vehicle to aggressiv ...

    STTR Phase II 2018 Department of DefenseAir Force
  7. Brain penetrant Hsp90 inhibitors for Alzheimer's disease

    SBC: YUMA THERAPEUTICS CORPORAITON            Topic: NIA

    DESCRIPTION provided by applicant Neurodegeneration in Alzheimerandapos s disease AD may result from deposition of A as plaques in brain tissue However less effort has been made to elucidate the role of tau containing neurofibrillary tangles NFTs in AD Accumulating evidence suggests that tau containing NFTs is an important component in the initiation and progression of AD and other neu ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Closed-Loop Extracranial Activation using Reinforcement-learning (CLEAR)

    SBC: Charles River Analytics, Inc.            Topic: AF17BT002

    Increased workloads and operational pressures can degrade human analysts cognitive performance, jeopardizing their ability to safely and effectively carry out mission-critical tasks. To avoid overload and maximize the potential of human operators, a method for conducting real-time evaluation of cognitive state, combined with means to dynamically enhance performance, is required. Novel technologies ...

    STTR Phase I 2018 Department of DefenseAir Force
  9. Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses

    SBC: IQ Medical Imaging LLC            Topic: 102

    Project SummaryAbstract The neurofibromatosesNFsincluding NFNFand schwannomatosisare a group of autosomal dominant neurogenetic disorders characterized by a predisposition in virtuallyof patients to develop multiple nerve sheath tumorsThe determination of tumor burden on magnetic resonance imagingMRIis indispensable for the longitudinal management of NF patientswhich includes life long follow up f ...

    STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  10. Coils for Human Whole Body Imaging at 7T

    SBC: LIFE SERVICES L.L.C.            Topic: NIBIB

    DESCRIPTION provided by applicant For this Phase II STTR proposal the investigators plan to develop and commercialize the radiofrequency RF coil technology to make T body MRI possible and to translate this new technology to vastly improve T clinical MRI as well In the Phase I project leading to this proposal all specific aims were accomplished to demonstrate the feasibility of safely an ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government